Catalyst

Slingshot members are tracking this event:

BioMarin's BMN-270 Hemophilia A updated data to be presented at JPM 2017

Source Link:
http://www.streetinsider.com/FDA/BioMarin%20Pharma%20(BMRN)%20says%20not%20presenting%20at%20ASH%202016%20-%20Bloomberg/12262696.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
BMRN
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details BMN-270 updated data initially expected to be presented at ASH, but it failed to present.
http://investors.bmr...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Jan 09, 2017
Occurred Source:
http://investors.biomarin.com/download/BMRN_JPM2017_FINAL_010917.pdf
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Bmn-270, Hemophilia A, Jpm 2017
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.